Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 3 studies | 33% ± 6% | |
ciliated cell | 3 studies | 23% ± 3% | |
GABAergic neuron | 3 studies | 24% ± 4% | |
glutamatergic neuron | 3 studies | 25% ± 9% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 18% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 1545.37 | 245 / 245 | 100% | 36.26 | 502 / 502 |
breast | 100% | 1894.05 | 459 / 459 | 100% | 40.99 | 1116 / 1118 |
esophagus | 100% | 1309.77 | 1445 / 1445 | 99% | 29.60 | 182 / 183 |
thymus | 100% | 1979.25 | 653 / 653 | 99% | 30.12 | 600 / 605 |
ovary | 100% | 1697.99 | 180 / 180 | 99% | 18.09 | 426 / 430 |
pancreas | 99% | 982.15 | 326 / 328 | 99% | 21.12 | 176 / 178 |
lung | 99% | 1212.35 | 573 / 578 | 99% | 30.34 | 1142 / 1155 |
adrenal gland | 100% | 2432.79 | 258 / 258 | 98% | 23.82 | 225 / 230 |
uterus | 100% | 1530.98 | 170 / 170 | 98% | 22.31 | 448 / 459 |
kidney | 100% | 1344.35 | 89 / 89 | 97% | 23.41 | 878 / 901 |
bladder | 100% | 1567.19 | 21 / 21 | 96% | 18.22 | 486 / 504 |
brain | 99% | 1561.47 | 2623 / 2642 | 96% | 31.74 | 678 / 705 |
intestine | 100% | 1274.38 | 966 / 966 | 95% | 18.13 | 501 / 527 |
skin | 100% | 1991.13 | 1807 / 1809 | 95% | 27.85 | 448 / 472 |
stomach | 100% | 1045.98 | 359 / 359 | 94% | 17.04 | 270 / 286 |
liver | 100% | 1009.03 | 226 / 226 | 89% | 12.64 | 360 / 406 |
adipose | 100% | 1733.16 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1797.65 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 1065.07 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 16.06 | 1 / 1 |
muscle | 98% | 877.28 | 788 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 27.71 | 44 / 45 |
heart | 93% | 893.65 | 804 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 91% | 18.54 | 73 / 80 |
lymph node | 0% | 0 | 0 / 0 | 66% | 6.66 | 19 / 29 |
peripheral blood | 46% | 286.51 | 424 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0034198 | Biological process | cellular response to amino acid starvation |
GO_0140469 | Biological process | GCN2-mediated signaling |
GO_0001933 | Biological process | negative regulation of protein phosphorylation |
GO_1990138 | Biological process | neuron projection extension |
GO_1990611 | Biological process | regulation of cytoplasmic translational initiation in response to stress |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0045666 | Biological process | positive regulation of neuron differentiation |
GO_0006446 | Biological process | regulation of translational initiation |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0008150 | Biological process | biological_process |
GO_0005575 | Cellular component | cellular_component |
GO_0005737 | Cellular component | cytoplasm |
GO_0043022 | Molecular function | ribosome binding |
GO_0140311 | Molecular function | protein sequestering activity |
GO_0005515 | Molecular function | protein binding |
GO_0003779 | Molecular function | actin binding |
GO_0003674 | Molecular function | molecular_function |
Gene name | IMPACT |
Protein name | Impact RWD domain protein Protein IMPACT (Imprinted and ancient gene protein homolog) IMPACT Protein IMPACT |
Synonyms | |
Description | FUNCTION: Translational regulator that ensures constant high levels of translation upon a variety of stress conditions, such as amino acid starvation, UV-C irradiation, proteasome inhibitor treatment and glucose deprivation. Plays a role as a negative regulator of the EIF2AK4/GCN2 kinase activity; impairs GCN1-mediated EIF2AK4/GCN2 activation, and hence EIF2AK4/GCN2-mediated eIF-2-alpha phosphorylation and subsequent down-regulation of protein synthesis. May be required to regulate translation in specific neuronal cells under amino acid starvation conditions by preventing GCN2 activation and therefore ATF4 synthesis. Through its inhibitory action on EIF2AK4/GCN2, plays a role in differentiation of neuronal cells by stimulating neurite outgrowth. . |
Accessions | ENST00000580035.1 J3KT25 ENST00000578221.1 J3QRS6 Q5GFE0 A0A3B3ITH3 ENST00000585067.5 J3QLU6 ENST00000648078.1 J3QQU0 Q9P2X3 ENST00000581278.1 ENST00000284202.9 [Q9P2X3-1] |